Both in Pharmaceuticals
Rapport Therapeutics vs Korsana Biosciences
Over the past year RAPP returned −41.7% and KRSA returned +0.2%; their daily moves had a correlation of 0.03.
RAPP −41.7% KRSA +0.2%Growth of $1, one year, split-adjusted
| Metric | RAPP | KRSA |
|---|---|---|
| Price | $25.44 | $31.96 |
| Market cap | $1.43B | $1.46B |
| Today | +1.23% | +0.95% |
| 1 month | −21.0% | +4.0% |
| 6 months | −28.5% | — |
| Year to date | −16.2% | — |
| 1 year | −12.1% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 71.6× | — |
| Net cash | $436.1M | — |
| Dividend yield | — | — |
| Volatility (60d) | 79.5% | — |
| Short % of float | 10.9% | 1.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).